Medical Foods Market - Top Companies and Manufacturers

  • Report ID: 6298
  • Published Date: Aug 02, 2024
  • Report Format: PDF, PPT

Companies Dominating the Medical Foods Landscape

    Medical foods market growth is predicted that these companies will occupy a tremendous share. Most of these companies are continuously collaborating, making agreements, expanding, and joining ventures for the growth of this industry. With the penetration of a sedentary lifestyle and various chronic diseases such as cancer, and cardiovascular diseases, various companies are adapting to improve dietary supplements to the latest trends and are set to be the major key players in this sector.

    Some of the key players include:

    • EraCal Therapeutics
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Lanfam LLC
    • Abbott
    • Targeted Medical Pharma Inc.
    • Primus Pharmaceuticals Inc.
    • Fresenius Kabi AG
    • Mead Johnson & Company, LLC
    • SFI Health
    • Danone

Browse Key Market Insights with Data Illustration:

In the News

  • In February 2023, EraCal Therapeutics and Nestlé S.A. collaborated on research to find the latest nutraceuticals relevant to controlling food intake.
  • In March 2022, the Lanfam LLC company introduced Proleeva, a new medical food designed to treat inflammatory conditions like neuropathy, osteoporosis, fibromyalgia, diabetic and rheumatoid arthritis, as well as chronic pain.

Author Credits:  Radhika Pawar


  • Report ID: 6298
  • Published Date: Aug 02, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2023, the industry size of the medical foods market was USD 23.6 billion.

The market size of the medical foods industry is expected to surpass USD 45.1 billion by the end of 2036 expanding at a CAGR of 5.5% during the forecast period i.e., between 2024-2036.

The major players in the market are Lanfam LLC, Abbott, Targeted Medical Pharma Inc., Primus Pharmaceuticals Inc., Fresenius Kabi AG, Mead Johnson & Company, LLC, SFI Health, Danone, and others.

In terms of route of administration, the oral segment is anticipated to garner the largest market share of 71.2% by 2036 and display substantial growth opportunities during 2024-2036.

The market in North America is projected to hold the largest revenue share of 46.9% by the end of 2036 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample